✦ LIBER ✦

Cyclophosphamide, cytosine arabinoside and methotrexate versus cytosine arabinoside and thioguanine for acute non-lymphocytic leukemia in adults

✍ Scribed by Roland T. Skeel; William Costello; John M. Bennett; Martin M. Oken; Mark S. Tobin; Joseph R. Bertino; John C. Marsh; Paul P. Carbone

Publisher: John Wiley and Sons
Year: 1980
Tongue: English
Weight: 720 KB
Volume: 45
Category: Article
ISSN: 0008-543X
DOI: 10.1002/1097-0142(19800115)45:2<224::aid-cncr2820450205>3.0.co;2-d

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Cytosine arabinoside and 6-thioguanine i

Cytosine arabinoside and 6-thioguanine in refractory acute lymphocytic leukemia

✍ Dr. J. Hugh Bryan; Edward S. Henderson; Brigid G. Leventhal 📂 Article 📅 1974 🏛 John Wiley and Sons 🌐 English ⚖ 478 KB 👁 2 views

Idarubicin and standard-dose cytosine ar

Idarubicin and standard-dose cytosine arabinoside in adults with recurrent and refractory acute lymphocytic leukemia

✍ Merat Karbasian-Esfahani; Peter H. Wiernik; Yelena Novik; Elisabeth Paietta; Jan 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 79 KB 👁 1 views

## Abstract ## BACKGROUND Drug resistance and early disease recurrence were major contributing factors in the limited survival of patients with acute lymphocytic leukemia (ALL). New chemotherapeutic agents and drug combinations were employed in refractory patients to overcome drug resistance. ##

Cytosine arabinoside and 6-thioguanine i

Cytosine arabinoside and 6-thioguanine in the treatment of childhood acute myeloblastic leukemia

✍ Hernan Moreno; Robert P. Castleberry; William P. McCann 📂 Article 📅 1977 🏛 John Wiley and Sons 🌐 English ⚖ 590 KB

Low-dose cytosine arabinoside in acute n

Low-dose cytosine arabinoside in acute non-lymphoblastic leukemia

✍ Lalit Kumar; V. Kochupillai; Harsch Dua 📂 Article 📅 1989 🏛 John Wiley and Sons 🌐 English ⚖ 408 KB 👁 2 views

Daunomycin, cytosine arabinoside and 6-t

Daunomycin, cytosine arabinoside and 6-thioguanine (DAT) vs vincristine, cytosine arabinoside and 6-thioguanine (VAT) in the induction treatment of acute nonlymphocytic leukemia: A randomized collaborative study

✍ Mandelli, F. ;de Lipsis, E. ;Grignani, F. ;Martelli, M. ;Liso, V. ;Amadori, S. 📂 Article 📅 1978 🏛 John Wiley and Sons 🌐 English ⚖ 471 KB

One hundred patients were entered in a cooperative study comparing the efficacy of two different regimens in the induction treatment of acute nonlymphocytic leukemia (ANLL). Patients were randomly allocated to receive either the DAT or VAT combination; half of the patients were also randomized to re

Mitoxantrone and high-dose cytosine arab

Mitoxantrone and high-dose cytosine arabinoside for the treatment of refractory acute lymphocytic leukemia

✍ Hagop M. Kantarjian; Ronald L. Walters; Michael J. Keating; Elihu H. Estey; SUSA 📂 Article 📅 1990 🏛 John Wiley and Sons 🌐 English ⚖ 447 KB 👁 2 views

Twenty-five adult patients with refractory acute lymphocytic leukemia received salvage therapy with mitoxantrone 5 mg/m2 intravenously over 1 hour daily for 5 days and cytosine arabinoside 3 g/m2 intravenously over 2 hours every 12 hours for six doses. Overall, nine patients (36%) achieved complete